No definition available.
Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo
AB1_HIV_INFECT_PARASITES_WIDE
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
119 |
4. Check minimum number of eventsNone |
119 |
5. Include endpointsNone |
119 |
6. Filter based on genotype QC (FinnGen only) |
93 |
Control definitions (FinnGen only)
- Control exclude
- AB1_HIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF13
Similar endpoints
↥List of similar endpoints to
Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo
based on the number of shared cases.
Similar with more cases:
- Certain infectious and parasitic diseases, including avohilmo
- Any operation in hilmo
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 93 | 24 | 69 |
| Unadjusted period prevalence (%) | 0.03 | 0.01 | 0.03 |
| Median age at first event (years) | 49.20 | 57.49 | 46.32 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 110
- Matched controls
- 1100
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WW200
NOMESCO Finland
Immunization
158.7
133.8
70
12
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
+∞
89.0
73
*
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
+∞
70.6
60
*
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
28.5
68.3
57
40
B23.8
ICD-10 Finland
HIV disease resulting in other specified conditions
+∞
54.9
48
*
B20.6
ICD-10 Finland
HIV disease resulting in Pneumocystis jirovecii pneumonia
+∞
36.5
33
*
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
12.1
26.0
30
33
B20.9
ICD-10 Finland
HIV disease resulting in unspecified infectious or parasitic disease
+∞
23.8
22
*
Z21
ICD-10 Finland
Asymptomatic human immunodeficiency virus [HIV] infection status
+∞
22.7
21
*
Z3231
NOMESCO Finland
Registered nurse
6.4
21.4
64
197
Z25.1
ICD-10 Finland
Need for immunization against influenza
20.1
19.9
30
20
Z2221
NOMESCO Finland
Medical doctor
5.2
16.8
59
200
B20.4
ICD-10 Finland
HIV disease resulting in candidiasis
+∞
16.0
15
*
B20.1
ICD-10 Finland
HIV disease resulting in other bacterial infections
+∞
14.9
14
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
5.0
14.2
78
362
B20.0
ICD-10 Finland
HIV disease resulting in mycobacterial infection
+∞
13.8
13
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.3
12.7
49
172
B23.0
ICD-10 Finland
Acute HIV infection syndrome
+∞
11.7
11
*
B20.3
ICD-10 Finland
HIV disease resulting in other viral infections
+∞
11.7
11
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
28.6
11.5
15
6
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.6
11.4
25
55
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
24.5
11.0
15
7
Z2446
NOMESCO Finland
Social worker
5.7
9.7
20
41
R4110
NOMESCO Finland
Physiotherapy
3.5
9.4
50
211
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.6
9.3
26
70
J05AB11
ATC
valaciclovir; oral
4.4
9.3
28
80
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
5.4
8.7
19
41
B20.7
ICD-10 Finland
HIV disease resulting in multiple infections
+∞
8.4
8
*
QAJ99
NOMESCO Finland
Other aesthetic operations on skin of head or neck
+∞
8.4
8
*
JN4BD
NOMESCO Finland
Extensive body CT
4.8
8.2
21
52
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.9
7.8
19
45
N06AB04
ATC
citalopram; systemic
3.5
7.8
34
125
Z3226
NOMESCO Finland
Physiotherapist
3.4
7.2
32
118
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.0
7.2
23
68
WYA30, ,
SPAT
42.8
6.8
8
*
WX110, ,
SPAT
4.6
6.6
17
42
XF400
NOMESCO Finland
ECG with 12 standard connections
3.4
6.6
29
106
A56.3
ICD-10 Finland
Chlamydial infection of anus and rectum
74.0
6.5
7
*
OAB43, ,
SPAT
0.2
6.3
9
317
TLC02
NOMESCO Finland
Simple extraction of IUD
28.5
6.3
8
*
B20.2
ICD-10 Finland
HIV disease resulting in cytomegaloviral disease
+∞
6.3
6
*
A54.0
ICD-10 Finland
Gonococcal infection of lower genitourinary tract without periurethral or accessory gland abscess
+∞
6.3
6
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.9
6.2
20
59
A63.0
ICD-10 Finland
Anogenital (venereal) warts
8.0
6.1
13
18
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
88
6
706.81
103.87
20.0
1.2
10925.02
—
u/ml
—
58
0
61
82
15.45
48.28
2.6
2.7
30.39
28.54
u/l
0.25
61
68
32
45
9.62
22.98
4.1
2.5
—
—
—
0
0
30
42
9.45
21.53
4.1
2.3
—
—
—
0
0
102
553
12.59
19.60
23.8
11.5
3.27
4.22
e9/l
6.62
97
485
87
376
7.28
19.19
17.7
3.7
30.92
34.25
u/l
0.63
87
358
88
398
7.06
18.00
6.8
5.8
37.66
36.28
g/l
1.39
88
381
95
510
7.33
14.55
5.9
3.4
0.00
0.00
estimate
-0.00
11
98
95
515
7.19
14.24
5.9
3.4
0.00
0.00
estimate
-0.00
12
99
95
526
6.91
13.57
6.0
3.4
0.00
0.00
estimate
—
10
89
16
5
36.99
12.98
1.1
1.0
—
—
—
0
0
22
38
6.99
12.84
1.3
1.4
179.00
296.34
miu/ml
—
6
20
38
113
4.61
12.20
4.1
2.2
—
—
—
0
0
36
103
4.71
12.13
3.7
2.1
—
—
—
0
0
43
144
4.26
11.76
4.4
2.9
0.82
0.99
e6/l
0.09
17
66
45
161
4.04
11.15
4.2
2.8
0.63
0.77
e6/l
0.14
19
83
60
263
3.82
11.02
5.1
3.1
0.12
0.35
e6/l
1.47
38
190
94
572
5.42
10.46
10.3
5.4
6.44
6.80
mmol/l
1.01
94
547
20
41
5.74
9.75
1.6
1.6
—
—
—
0
0
9
0
+∞
9.51
4.9
0.0
—
—
—
0
0
19
28
7.97
8.52
4.2
9.1
7539.40
219.60
iu/ml
—
5
5
18
27
7.75
7.99
2.7
2.5
0.75
3.46
index
—
8
13
13
11
13.20
7.81
4.5
3.0
—
—
—
0
0
16
22
8.31
7.51
1.1
1.3
—
—
—
0
0
17
29
6.73
6.95
2.1
1.6
—
—
—
0
0
17
30
6.50
6.79
1.2
1.3
1.44
0.14
iu/ml
—
7
5
18
35
5.94
6.68
1.3
1.2
—
—
—
0
0
22
71
3.62
6.01
3.5
2.6
66.91
69.67
ml/min/173m2
0.13
11
33
13
19
7.60
5.94
2.7
1.3
—
—
—
0
0
10
9
12.07
5.92
4.4
3.0
—
—
—
0
0
16
35
5.17
5.44
3.9
2.7
—
—
—
0
0
9
10
9.67
4.88
1.4
1.8
—
—
—
0
0
16
48
3.73
4.82
3.7
2.9
24.13
24.87
mmol/l
0.42
16
48
68
453
2.31
4.32
9.4
8.2
1.20
1.20
mmol/l
0.47
58
406
26
116
2.63
4.04
2.2
1.8
—
—
—
0
0
31
151
2.47
4.02
2.0
1.9
—
—
—
0
0
11
23
5.19
3.99
3.8
1.4
—
—
—
0
0
25
113
2.57
3.77
2.2
1.9
—
—
—
0
0
16
57
3.11
3.71
21.1
10.5
24.94
24.84
mmol/l
0.04
16
57
6
6
10.48
3.54
1.5
1.5
620.17
509.50
u/ml
—
6
6
17
66
2.86
3.40
1.4
1.6
—
—
—
0
0
8
16
5.30
3.11
1.4
1.9
—
—
—
0
0
8
16
5.30
3.11
1.4
1.9
—
—
—
0
0
7
12
6.14
3.07
1.1
1.1
—
—
—
0
0
16
64
2.76
3.03
3.3
4.1
89.56
88.70
ng/l
0.01
16
58
5
5
10.38
3.01
1.2
2.8
—
—
—
0
0
19
84
2.53
2.97
2.3
2.9
—
—
—
0
0
16
66
2.67
2.86
1.4
1.6
0.29
0.24
mg/l
—
10
31
105
938
3.62
2.70
30.4
14.2
83.23
85.29
ml/min/173m2
0.51
100
875
10
30
3.56
2.68
1.5
2.4
3.78
3.44
g/l
—
10
30
22
382
0.47
2.59
3.4
3.7
15.64
46.96
ng/l
1.91
11
260
54
379
1.83
2.50
2.0
2.0
90.96
91.20
pmol/l
0.01
31
195
7
19
3.86
2.19
1.1
1.2
—
—
—
0
0
34
215
1.84
2.14
2.5
2.3
—
—
—
0
0
105
959
3.09
2.07
25.5
15.0
22.96
24.01
mg/l
0.15
94
774
6
15
4.17
2.07
1.2
1.2
—
—
—
0
0
9
34
2.79
1.91
1.1
2.0
95.89
92.15
%
—
9
34
5
12
4.31
1.84
1.2
1.4
—
—
—
0
0
30
192
1.77
1.79
4.1
3.4
28.82
344.89
ng/l
1.38
22
153
26
386
0.57
1.68
6.0
3.3
0.18
0.00
estimate
0.47
11
85
17
92
2.00
1.67
1.8
1.4
—
—
—
0
0
5
14
3.69
1.63
1.4
1.4
—
—
—
0
0
8
32
2.61
1.63
1.1
1.3
—
—
—
0
0
6
21
2.96
1.53
1.2
1.4
—
—
—
0
0
23
144
1.76
1.47
17.1
7.8
104.83
104.25
mmol/l
0.29
23
144
20
296
0.60
1.21
7.0
2.8
0.00
0.01
estimate
0.49
11
79
41
314
1.49
1.15
2.4
2.2
114.07
187.93
u/l
1.92
41
306
5
22
2.33
1.04
1.0
1.7
—
—
—
0
0
52
430
1.40
0.93
3.0
2.8
—
—
estimate
—
0
0
74
652
1.41
0.90
3.6
3.0
—
—
—
0
0
23
164
1.51
0.89
2.6
2.4
13.15
14.19
umol/l
0.27
23
152
13
80
1.71
0.89
1.9
2.6
0.21
0.23
g/l
0.46
13
71
5
99
0.48
0.82
2.4
7.6
—
—
—
0
0
6
33
1.86
0.80
1.3
1.5
2.06
1.72
mg/l
—
6
24
5
23
2.23
0.77
1.2
1.9
—
—
—
0
0
5
24
2.13
0.75
1.4
1.5
—
—
—
0
0
5
26
1.97
0.71
1.2
1.1
—
—
—
0
0
5
27
1.89
0.69
1.0
1.1
2.00
37.57
e6/l
—
5
21
5
28
1.82
0.67
1.0
1.3
17.40
95.64
e6/l
—
5
22
19
141
1.42
0.61
2.9
2.3
25.53
24.34
%
0.08
19
133
34
406
0.76
0.60
3.5
4.0
22.57
21.74
%
—
9
153
22
170
1.37
0.57
1.4
1.5
—
—
—
0
0
6
38
1.61
0.55
1.0
1.3
—
—
—
0
0
37
317
1.25
0.47
4.7
4.3
21.99
8.33
mg/mmol
0.67
24
213
0
15
0.00
0.41
0.0
3.7
—
1604.28
—
0
15
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
22
264
0.79
0.39
5.1
3.7
0.00
0.00
estimate
-0.00
11
93
5
36
1.41
0.38
1.0
1.2
—
—
—
0
0
73
768
0.85
0.28
4.9
3.5
68.22
53.02
u/l
0.45
67
739
28
315
0.85
0.26
2.7
2.8
0.55
0.71
ug/l
1.02
19
160
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
3.1
—
0.91
—
0
11
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
6
47
1.29
0.21
1.8
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
1.14
—
0
7
7
59
1.20
0.18
1.9
3.8
1.24
1.22
mmol/l
—
7
54
16
179
0.88
0.13
2.4
2.5
16.23
14.96
nmol/l
0.29
16
173
7
81
0.86
0.07
1.3
1.5
—
—
—
0
0
9
87
1.04
0.07
3.0
4.5
2.97
58.56
ug/l
—
9
69
12
116
1.04
0.00
1.7
2.6
321.42
394.44
nmol/l
0.80
12
107
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
121.00
—
0
6
0
5
0.00
0.00
0.0
6.4
—
57.80
—
0
5
0
6
0.00
0.00
0.0
1.3
—
57.85
—
0
6
0
6
0.00
0.00
0.0
1.5
—
8.67
—
0
6
0
6
0.00
0.00
0.0
1.3
—
6.45
—
0
6
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
3.4
—
199.34
—
0
5
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
5.7
—
10.49
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
19.70
—
0
7
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.9
—
105.29
—
0
7
0
8
0.00
-0.00
0.0
5.8
—
4.58
—
0
8
0
8
0.00
-0.00
0.0
2.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
-0.00
0.0
2.6
—
116.71
—
0
7
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
13.38
—
0
8
0
8
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.7
—
222.86
—
0
7
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: AB1_HIV_INFECT_PARASITES_WIDE – Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases, including avohilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).